Boehringer buys immunotherapy biotech AMAL TherapeuticsGermany’s Boehringer Ingelheim has bought the Swiss biotech AMAL Therapeutics, a privately-held Swiss biotech focused on immunotherapy and Share XBoehringer buys immunotherapy biotech AMAL Therapeuticshttps://pharmaphorum.com/news/boehringer-buys-immunotherapy-biotech-amal-therapeutics/
